Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
BMC Cancer|January 22, 2014
Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cellsJian Kang, C Marcelo Sergio, Robert L Sutherland, et al.
Cell Cycle (Georgetown, Tex.)|January 18, 2013
Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Robert L Sutherland, et al.
Molecular and Cellular Endocrinology|December 21, 2004
Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1Amanda Mawson, Angela Lai, Jason S Carroll, et al.
Cell Cycle (Georgetown, Tex.)|January 18, 2013
Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1C Elizabeth Caldon, C Marcelo Sergio, Andrew Burgess, et al.
Cancers|August 23, 2020
Cyclin E2 Promotes Whole Genome Doubling in Breast CancerChristine Lee, Kristine J Fernandez, Sarah Alexandrou, et al.
Molecular and Cellular Biology|July 1, 2009
Estrogen regulation of cyclin E2 requires cyclin D1 but not c-MycC Elizabeth Caldon, C Marcelo Sergio, Judith Schütte, et al.
Oncogene|October 19, 2004
Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1Alexander Swarbrick, Mia C Akerfeldt, Christine S L Lee, et al.
Cancer Research|September 19, 2007
Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptorEileen M McGowan, Amanda J Russell, Viroj Boonyaratanakornkit, et al.
Advances in Experimental Medicine and Biology|May 24, 2008
Identification of downstream targets of estrogen and c-myc in breast cancer cellsElizabeth A Musgrove, C Marcelo Sergio, Luke R Anderson, et al.
Breast Cancer Research : BCR|April 1, 2008
The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcomeAlison J Butt, C Marcelo Sergio, Claire K Inman, et al.
Pageof 3